Non-nutritive Sweeteners in Inflammatory Bowel Disease

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This study will focus on the commonly used non-nutritive sweetener (NNS) sucralose (2 sachets/day resulting in daily dose: sucralose 2.5mg/kg) and its role in changing the gut microbiota in humans with IBD, compared to healthy non-IBD individuals. We will focus on studying IBD patients affected with CD as a proof of principle that could be tested later in other IBD subtype (ulcerative colitis or others specific surgical conditions).
Epistemonikos ID: 0e45332e3bf6ffd6f14286d4612bc543e1d34484
First added on: Aug 19, 2026